Showing results (81-90 of 925) with videos related to

Sort By:
Pageof 93
Journal of Immunology (Baltimore, Md. : 1950)|January 5, 2007
Oxidized phospholipids inhibit phagocytosis and impair outcome in gram-negative sepsis in vivoSylvia Knapp, Ulrich Matt, Norbert Leitinger, et al.
Expert Review of Anti-Infective Therapy|June 26, 2014
The coagulation system in melioidosis: from pathogenesis to new treatment strategiesLiesbeth Martine Kager, Tom van der Poll, Willem Joost Wiersinga
Microbes and Infection|July 26, 2008
Gene-expression profiles in murine melioidosisW Joost Wiersinga, Mark C Dessing, Tom van der Poll
Biomedicines|September 23, 2022
The End of "One Size Fits All" Sepsis Therapies: Toward an Individualized ApproachJean-Louis Vincent, Tom van der Poll, John C Marshall
World Journal of Stem Cells|March 28, 2015
Mesenchymal stem cells as a therapeutic tool to treat sepsisEleuterio Lombardo, Tom van der Poll, Olga DelaRosa, et al.
Blood|April 19, 2003
Plasminogen activator inhibitor type-1 deficiency does not influence the outcome of murine pneumococcal pneumoniaAnita W Rijneveld, Sandrine Florquin, Paul Bresser, et al.
The Journal of Infectious Diseases|June 8, 2004
Inhibition of the tissue factor/factor VIIa pathway does not influence the inflammatory or antibacterial response to abdominal sepsis induced by Escherichia coli in miceSebastian Weijer, Saskia H H F Schoenmakers, Sandrine Florquin, et al.
The Journal of Infectious Diseases|October 8, 2010
Therapeutic recombinant murine activated protein C attenuates pulmonary coagulopathy and improves survival in murine pneumococcal pneumoniaMarcel Schouten, Cornelis van 't Veer, Florry E van den Boogaard, et al.
Seminars in Respiratory and Critical Care Medicine|July 1, 2024
Dysregulation of Host-Pathogen Interactions in Sepsis: Host-Related FactorsSebastiaan C M Joosten, Willem J Wiersinga, Tom van der Poll
Pageof 93